Development of a Screening Tool By Utilising Cervical Length Measurement In Relation To Body Mass Index (BMI) For Early Identification And Intervention Of Preterm Birth
Towards Development of an Individualised Screening Tool By Utilising Cervical Length Measurement In Relation To Body Mass Index (BMI) For Early Identification And Intervention Of Preterm Birth
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
General Objective To assess the association between body mass index, cervical length and risk of preterm birth.
Specific Objectives
- To examine the relationship between body mass index and cervical length
- To identify cut-off value of cervical length leading to high risk of spontaneous preterm birth among Malaysian women
- To assess the association between different cervical length and preterm birth
- To examine the association between body mass index and preterm birth
- To develop an individualised screening tool for assessing risk of preterm birth
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Selangor Darul Ehsan
-
Serdang, Selangor Darul Ehsan, Malaysia, 43400
- Hospital Pengajar UPM
-
Serdang, Selangor Darul Ehsan, Malaysia, 43400
- Hospital Serdang
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Singleton pregnancy between 16-24 weeks gestation
- No history of previous spontaneous preterm birth (gestation between 24-36+6 weeks)
- Agreement to follow up and consented for the study
Exclusion Criteria:
- Major fetal anomaly
- Multiple pregnancy
- Uterine anatomic malformation
- Those require iatrogenic preterm delivery due to various condition
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. To examine the relationship between body mass index (BMI) and cervical length (CL)
Time Frame: till February 2023
|
Association of BMI and CL
|
till February 2023
|
|
2. To identify cut-off value of cervical length
Time Frame: till February 2023
|
Value leading to high risk of spontaneous preterm birth among Malaysian women
|
till February 2023
|
|
3. To assess the association between different cervical length and preterm birth
Time Frame: till February 2023
|
Association of CL and PTB
|
till February 2023
|
|
4. To examine the association between body mass index and preterm birth
Time Frame: till February 2023
|
Association of BMI and PTB
|
till February 2023
|
|
5. To develop an individualised screening tool for assessing risk of preterm birth
Time Frame: Till May 2023
|
Attributable risk of preterm birth with relation to BMI and CL
|
Till May 2023
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GM-IPM/2021/9695300
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.